Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system

Area of Science:

• Biochemistry
• Molecular Biology
• Assay Development

Background:

• Accurate antigen quantification at low concentrations is crucial for biomarker identification and protein interaction studies in proteomics.
• High-throughput microarrays require sensitive assays to detect disease-associated biomarkers.

Purpose of the Study:

• To develop an ultrasensitive quantitative assay format, immunoliposome polymerase chain reaction (ILPCR), for antigen detection.
• To meet the need for wide dynamic range and high sensitivity in biomarker discovery and proteomics.

Main Methods:

• Developed a liposome detection reagent with encapsulated reporter DNA and biotinylated PEG phospholipids.
• Immobilized target antigen using a capture antibody and linked liposomes via a NeutrAvidin bridge to a second antibody.
• Ruptured liposomes to release reporter DNA for quantification using real-time PCR.

Main Results:

• The ILPCR assay demonstrated a linear dose-response from 10⁻¹⁰ M to 10⁻¹⁶ M for carcinoembryonic antigen (CEA).
• Achieved a detection limit of 13 fg/mL for CEA, 1,500 times more sensitive than current clinical assays.
• Exhibited low coefficients of variance (<6% repeatability, <2% reproducibility) for CEA quantification in human serum.

Conclusions:

• ILPCR simplifies detection reagent preparation through spontaneous incorporation of components.
• Encapsulation of reporter DNA enhances quantitative accuracy by allowing DNase I treatment to remove nonspecific DNA.
• Multiple reporters per liposome mitigate polymerase inhibitors, and the generic biotinylated system supports diverse applications.